Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT).

OBJECTIVE The combination of both morphological and cellular markers of subclinical atherosclerosis, in addition to conventional risk factors, may help to improve cardiovascular prevention in type 2 diabetic patients. The aim of our cross-sectional study was to evidence a putative increase in endothelial (EMP) or platelet (PMP) microparticles, in type 2 diabetic patients with coronary noncalcified plaques detected by multidetector CT (MDCT). METHODS AND RESULTS Microparticles and coronary MDCT were assessed in 56 type 2 diabetic patients with different cardiovascular risk levels. Both EMP (r=0.35, p=0.022) and PMP (rho=0.34, p=0.022) were correlated with hsCRP. EMP were elevated in patients with acute coronary syndromes (p=0.034). EMP count was significantly higher in the presence of noncalcified diseased segments (p=0.01). By contrast, there was no association between hsCRP and noncalcified atheroma. This increase in EMP in noncalcified diseased segment carriers remained borderline significant after adjustment for coronary heart disease and hsCRP. Conversely, there was no association of PMP count with noncalcified diseased segments and no difference in PMP count between patients with and without acute coronary syndrome. No significant association between either EMP and PMP counts and mixed or calcified diseased segments was observed. CONCLUSIONS We report for the first time an association between plasma EMP-CD144+ and coronary noncalcified plaques assessed by MDCT in a population of type 2 diabetic patients. EMP might be used as a surrogate marker of unstable plaques, and might help to improve cardiovascular prediction in diabetic patients with intermediate risk.

[1]  Jonathan G Goldin,et al.  Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiolog , 2006, Circulation.

[2]  R. Virmani,et al.  Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies , 2002, Circulation.

[3]  S. Achenbach,et al.  Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography: A Segment-Based Comparison With Intravascular Ultrasound , 2003, Circulation.

[4]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[5]  L. Horstman,et al.  Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes , 2004 .

[6]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[7]  G. Raff,et al.  Coronary angiography by computed tomography: coronary imaging evolves. , 2007, Journal of the American College of Cardiology.

[8]  L. Køber,et al.  Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. , 1999, European heart journal.

[9]  Hirofumi Anno,et al.  Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.

[10]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[11]  A. D. Black,et al.  Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. , 2004, Biochemical and biophysical research communications.

[12]  P. Touboul,et al.  Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  D. Cox,et al.  Young male smokers have altered platelets and endothelium that precedes atherosclerosis. , 2004, The Journal of surgical research.

[14]  Jeroen J. Bax,et al.  Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. , 2007, Journal of the American College of Cardiology.

[15]  C. Loria,et al.  Age and the burden of death attributable to diabetes in the United States. , 2002, American journal of epidemiology.

[16]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[17]  C. Lamendola,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. , 2002, Circulation.

[18]  William W O'Neill,et al.  A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. , 2007, Journal of the American College of Cardiology.

[19]  K. Kugiyama,et al.  Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. , 2006, European heart journal.

[20]  L. Horstman,et al.  Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.

[21]  Daniel S Berman,et al.  Prognostic value of coronary artery calcium screening in subjects with and without diabetes. , 2004, Journal of the American College of Cardiology.

[22]  Daniel S Berman,et al.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. , 2007, Journal of the American College of Cardiology.

[23]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  Nikos Werner,et al.  Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.

[26]  A. Tedgui,et al.  Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. , 2006, Hypertension.

[27]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[28]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[29]  P. Moulin,et al.  Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. , 2005, Diabetes care.

[30]  M. Budoff,et al.  Progression of Coronary Artery Calcium and Occurrence of Myocardial Infarction in Patients With and Without Diabetes Mellitus , 2005, Hypertension.

[31]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.